Sector: Biotechnology - Drug Delivery
Medical Field: Oncology
Technological Field: Drug/Gene Delivery
Year Established: 1999
PolyGene, Ltd. is involved in developing innovative technologies for delivering drugs and genes into the human body using unique polymers. The company operates in two main directions:
- Developing a technology for localized treatment of solid tumors, which enables delivery of a high dose of the chemotherapy drug, thereby increasing the chance for recovery while significantly reducing the side effects usually associated with having the drug dispersed throughout the entire body.
- Developing a technology that enables peptides and proteins to be delivered at varying intervals, such as one month to 4-5 months, in patients who require injections on a daily basis throughout their entire lives.